BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 24369224)

  • 1. Secondary neurolymphomatosis detected by whole-body diffusion-weighted magnetic resonance imaging: a case report.
    Tanaka H; Yoshino K; Sakaida E; Hashimoto S; Takeda Y; Kawajiri C; Takagi T; Nakaseko C
    J Clin Exp Hematop; 2013; 53(3):221-6. PubMed ID: 24369224
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Primary neurolymphomatosis of the cervical nerve root].
    Miki M; Masaki Y; Nakamura T; Iwao H; Nakajima A; Sakai T; Sawaki T; Kawanami T; Kaito M; Kurose N; Fujita Y; Tanaka M; Fukushima T; Hirose Y; Umehara H
    Rinsho Ketsueki; 2010 Jul; 51(7):564-7. PubMed ID: 20693778
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reversal of neurological deficit after chemotherapy in BCL-6-positive neurolymphomatosis. Case report.
    Peruzzi P; Ray-Chaudhuri A; Slone WH; Mekhjian HS; Porcu P; Chiocca E
    J Neurosurg; 2009 Aug; 111(2):247-51. PubMed ID: 19216652
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A rare case of primary high-grade large B-cell lymphoma of the sciatic nerve.
    Advani P; Paulus A; Murray P; Jiang L; Goff R; Pooley R; Jain M; Garner H; Foran J
    Clin Lymphoma Myeloma Leuk; 2015 Jun; 15(6):e117-20. PubMed ID: 25617034
    [No Abstract]   [Full Text] [Related]  

  • 5. Evaluation of staging and early response to chemotherapy with whole-body diffusion-weighted MRI in malignant lymphoma patients: A comparison with FDG-PET/CT.
    Tsuji K; Kishi S; Tsuchida T; Yamauchi T; Ikegaya S; Urasaki Y; Fujiwara Y; Ueda T; Okazawa H; Kimura H
    J Magn Reson Imaging; 2015 Jun; 41(6):1601-7. PubMed ID: 25111444
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Primary adrenal lymphoma presenting as neurolymphomatosis: A case report.
    Chen Z; Lin L; Xu L; Lin R; Jiang X
    Medicine (Baltimore); 2024 Mar; 103(12):e37558. PubMed ID: 38518055
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [A case of neurolymphomatosis presenting extended involvement of spinal nerve roots].
    Sato M; Furuta M; Hirayanagi K; Nagamine S; Makioka K; Ikeda Y
    Rinsho Shinkeigaku; 2015; 55(5):333-8. PubMed ID: 26028196
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relapsed lymphoma mimicking venous ulcer: A case report.
    Kamal WSA; Affandi AM; Bhullar A; Kamal WSZ
    Med J Malaysia; 2018 Aug; 73(4):253-254. PubMed ID: 30121690
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multiple secondary cauda equina non-Hodgkin's lymphoma: a case report and literature review.
    Ban Y; Jing Z; Zou J
    BMC Cancer; 2019 Jun; 19(1):594. PubMed ID: 31208357
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Therapeutic management of central nervous system lymphomas in a single hematological institute].
    Iványi JL; Marton E; Plander M; Gyánó G; Czumbil L; Tóth C
    Orv Hetil; 2009 Oct; 150(42):1937-44. PubMed ID: 19812012
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic significance of interim ¹⁸F-FDG PET/CT after three or four cycles of R-CHOP chemotherapy in the treatment of diffuse large B-cell lymphoma.
    Yang DH; Min JJ; Song HC; Jeong YY; Chung WK; Bae SY; Ahn JS; Kim YK; Bom HS; Chung IJ; Kim HJ; Lee JJ
    Eur J Cancer; 2011 Jun; 47(9):1312-8. PubMed ID: 21334197
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neurolymphomatosis: diagnosis, management, and outcomes in patients treated with rituximab.
    Gan HK; Azad A; Cher L; Mitchell PL
    Neuro Oncol; 2010 Feb; 12(2):212-5. PubMed ID: 20150388
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 3A Comparison between R-THP-COP and R-CHOP Regimens for the Treatment of Diffuse Large B-cell Lymphoma in Old Patients: A Single-institution Analysis.
    Araie H; Sakamaki I; Matsuda Y; Tai K; Ikegaya S; Itoh K; Kishi S; Oiwa K; Okura M; Tasaki T; Hosono N; Ueda T; Yamauchi T
    Intern Med; 2017 Sep; 56(18):2407-2413. PubMed ID: 28824057
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rituximab, cyclophosphamide-fractionated, vincristine, doxorubicin and dexamethasone alternating with rituximab, methotrexate and cytarabine overcomes risk features associated with inferior outcomes in treatment of newly diagnosed, high-risk diffuse large B-cell lymphoma.
    Mato A; Feldman T; Zielonka T; Singavi A; Gadaletta G; Waksmundzki K; Bhattacharyya P; Chow KF; Yang X; Panush D; Agress H; Rosario M; Howlett C; Pecora A; Goy A
    Leuk Lymphoma; 2013 Dec; 54(12):2606-12. PubMed ID: 23488604
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Neurolymphomatosis: diagnosis of extension and assessment of response to treatment with PET-CT].
    Durán C; Infante JR; Serrano J; Rayo JI; García L; Domínguez ML; Sánchez R
    Rev Esp Med Nucl; 2009; 28(6):295-8. PubMed ID: 19864049
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Primary diffuse large B-cell lymphoma of the uterine cervix successfully treated with rituximabplus cyclophosphamide, doxorubicin, vincristine, and prednisone chemotherapy-a case report].
    Hashimoto A; Fujimi A; Kanisawa Y; Matsuno T; Okuda T; Minami S; Doi T; Ishikawa K; Uemura N; Jyomen Y; Tomaru U
    Gan To Kagaku Ryoho; 2013 Dec; 40(13):2589-92. PubMed ID: 24335377
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Strikingly high false positivity of surveillance FDG-PET/CT scanning among patients with diffuse large cell lymphoma in the rituximab era.
    Avivi I; Zilberlicht A; Dann EJ; Leiba R; Faibish T; Rowe JM; Bar-Shalom R
    Am J Hematol; 2013 May; 88(5):400-5. PubMed ID: 23423884
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phase II study of the tetrahydropyranyl adriamycin-cyclophosphamide, vincristine, and prednisolone regimen combined with rituximab as first-line treatment for elderly patients with diffuse large B-cell lymphoma.
    Kasahara S; Hara T; Tsurumi H; Goto N; Kitagawa J; Kanemura N; Yoshikawa T; Goto H; Fukuno K; Yamada T; Sawada M; Takahashi T; Takami T; Moriwaki H
    Leuk Lymphoma; 2011 Apr; 52(4):629-34. PubMed ID: 21438831
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [A case of secondary central nervous system lymphoma presenting marked hypoglycorrhachia].
    Yamashita A; Tokuda M; Matsuo M; Irie J; Tateishi Y; Mutsukura K
    Rinsho Shinkeigaku; 2019 Jun; 59(6):365-370. PubMed ID: 31142712
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diffuse large B-cell lymphoma presenting as a sacral tumor. Report of two cases.
    Liu JK; Kan P; Schmidt MH
    Neurosurg Focus; 2003 Aug; 15(2):E10. PubMed ID: 15350041
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.